Mace Rothenberg

Insider Reports History

Entity
Individual
Location
171 Oyster Point Blvd., Suite 400, South San Francisco, CA
Signature
/s/ Douglas Barry, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mace Rothenberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. Director Common Stock 31.3K $118K $3.78 Nov 18, 2024 Direct
Tango Therapeutics, Inc. Director Stock Option (Right to Buy) 37.5K Jun 5, 2024 Direct
Surrozen, Inc./DE Director Option (right to buy) 1.33K Jun 5, 2024 Direct

Insider Reports Filed by Mace Rothenberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TNGX Tango Therapeutics, Inc. Nov 14, 2024 2 $74K 4 Nov 18, 2024 Director
TNGX Tango Therapeutics, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
SRZN Surrozen, Inc./DE Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
TNGX Tango Therapeutics, Inc. Jun 6, 2023 2 $0 4 Jun 8, 2023 Director
SRZN Surrozen, Inc./DE May 18, 2023 1 $0 4 May 19, 2023 Director
TNGX Tango Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 28, 2022 Director
SRZN Surrozen, Inc./DE Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
SRZN Surrozen, Inc./DE Aug 11, 2021 0 $0 3 Aug 16, 2021 Director
TNGX Tango Therapeutics, Inc. Aug 10, 2021 0 $0 3 Aug 12, 2021 Director